QuidelOrtho (QDEL) EBIT (2021 - 2024)

QuidelOrtho (QDEL) has 4 years of EBIT data on file, last reported at -$1.8 billion in Q1 2024.

• For the quarter ending Q1 2024, EBIT fell 1865.06% year-over-year to -$1.8 billion; the trailing twelve-month figure through Mar 2024 stood at -$2.4 billion (down 531.73% YoY), and the FY2024 full-year result was -$2.0 billion, down 1509.71% from the prior year.
• EBIT slipped to -$1.8 billion in Q1 2024, from -$618.1 million in the prior quarter.
• In the past five years, EBIT ranged from a high of $620.7 million in Q2 2022 to a low of -$1.8 billion in Q1 2024.
• A 4-year average of -$81.9 million and a median of $56.8 million in 2022 frame the typical range for EBIT.
• Across the five-year window, EBIT surged 242.06% in 2022 and plunged 1865.06% in 2024, its largest moves.
• Tracing QDEL's EBIT over 4 years: stood at $281.8 million in 2021, then slumped by 79.84% to $56.8 million in 2022, then tumbled by 1188.2% to -$618.1 million in 2023, then sank by 184.42% to -$1.8 billion in 2024.
• Business Quant data shows QDEL's EBIT at -$1.8 billion in Q1 2024, -$618.1 million in Q4 2023, and $26.3 million in Q4 2023.